Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2018-11-02 Regulatory Filings
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 October 2018
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content is focused on changes in the company's share capital structure during a specific month. There is no indication of financial performance data, earnings, management discussion, or audit information. The document is a regulatory filing reporting share capital movements, typical for compliance with exchange rules. It is not an annual or interim report, earnings release, or management report. Given the detailed nature and regulatory submission context, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-11-02 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 October 2018
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other movements in issued share capital. The content is focused on changes in the company's share capital structure during a specific month. There is no indication of financial performance data, earnings, management discussion, or audit information. The document is a regulatory filing reporting share capital movements, typical of a monthly return or shareholding update to the exchange. It does not fit categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement about share capital movements, which aligns best with the category 'Share Issue/Capital Change' (SHA). The document length is substantial and contains detailed data, so it is not a mere announcement of a report (RPA) or a fallback regulatory filing (RNS). Therefore, the classification is SHA with high confidence.
2018-11-01 English
MAJOR TRANSACTION SUBSCRIPTION IN YUZHOU PROPERTIES COMPANY LIMITED
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from Overseas Chinese Town (Asia) Holdings Limited dated 26 October 2018, concerning a major transaction involving a subscription in Yuzhou Properties Company Limited. It includes detailed information about the subscription agreement, terms, parties involved, conditions precedent, completion details, and financial information appendices. The document is lengthy (15,000 characters) and contains substantive content about the transaction and financial details, not merely an announcement or a brief summary. It is not a full annual or interim report, nor an earnings release or call transcript. It is a formal circular providing detailed information to shareholders about a major transaction, which aligns with the nature of a Proxy Solicitation & Information Statement (PSI), as it is intended to inform shareholders and seek their approval for the transaction as required by listing rules. Therefore, the most appropriate classification is Proxy Solicitation & Information Statement (PSI).
2018-10-25 English
INSIDE INFORMATION POTENTIAL DISPOSAL OF 100% EQUITY INTEREST IN A SUBSIDIARY THROUGH PUBLIC TENDER
Capital/Financing Update Classification · 95% confidence The document is an announcement by Overseas Chinese Town (Asia) Holdings Limited regarding a potential disposal of 100% equity interest in a subsidiary through a public tender. It references compliance with the Listing Rules and Inside Information Provisions, indicating it is a regulatory announcement. The content focuses on the intention to dispose of a subsidiary, the strategic reasons, and the procedural status, without containing financial statements or detailed financial data. The document is about a potential transaction but does not constitute a merger or acquisition filing itself, nor does it provide financial results or management discussion. It is a formal disclosure of a material transaction event, fitting the category of Capital/Financing Update (CAP) as it relates to changes in the company's capital structure through disposal of a subsidiary. The document length is just over 5,000 characters, but the content is clearly an announcement of a potential disposal, not a full report or detailed financial supplement. Therefore, the best classification is CAP with high confidence.
2018-10-25 English
CHANGE OF PRINCIPAL PLACE OF BUSINESS
Board/Management Information Classification · 95% confidence The document is a short announcement from the board of directors about a change in the company's principal place of business. It does not contain financial data, audit information, voting results, or any detailed report content. It is an official announcement related to company management but specifically about a change in the principal place of business, which is a management/board-related update. Therefore, it fits best under Board/Management Information (MANG). The document length is only 1421 characters, indicating it is a brief announcement rather than a full report.
2018-10-24 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 30 September 2018
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/09/2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, and other share-related activities. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing related to share capital movements and does not contain financial statements or management discussion. The document length is about 15,000 characters, indicating it is a full filing rather than a brief announcement. Given the nature of the content and the regulatory context, this filing best fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2018-10-08 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.